GSK plc (LON:GSK)
London
· Delayed Price · Currency is GBP · Price in GBX 1,336.50
-9.00 (-0.67%)
Apr 17, 2025, 5:18 PM BST
GSK plc Revenue
In the year 2024, GSK plc had annual revenue of 31.38B GBP with 3.46% growth. GSK plc had revenue of 8.12B in the quarter ending December 31, 2024, with 0.81% growth.
Revenue
31.38B
Revenue Growth
+3.46%
P/S Ratio
1.73
Revenue / Employee
457.18K
Employees
68,629
Market Cap
54.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
| Genus | 671.60M |
GSK plc News
- 1 day ago - UK approves combination therapies of GSK's blood cancer drug Blenrep - Reuters
- 2 days ago - Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer's Disease - GlobeNewsWire
- 2 days ago - AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices - Business Wire
- 2 days ago - GSK’s meningococcal vaccine gets positive recommendation from ACIP - Seeking Alpha
- 2 days ago - GSK's 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices - Business Wire
- 3 days ago - GSK is misleading prescription information on Omjjara, PMCPA says - Seeking Alpha
- 4 days ago - GSK in breach for misleading prescribing information on Omjjara, industry body says - Reuters
- 4 days ago - Goldman cites a “positive surprise” for GSK ahead of ACIP meeting on RSV shot - Seeking Alpha